Late gadolinium enhancement CMR for detecting myocardial injury after cancer therapy: a real-world observational study - Report - MDSpire

Late gadolinium enhancement CMR for detecting myocardial injury after cancer therapy: a real-world observational study

  • By

  • Xi Liu

  • Yue Gao

  • Zhen Wang

  • Wei-Feng Yan

  • Rui Shi

  • Yuan Li

  • Ying-Shi Sun

  • Zhi-Gang Yang

  • May 1, 2026

  • 0 min

Share

Clinical Report: Utilizing Late Gadolinium Enhancement Cardiac MRI to Identify Myocardial Damage Following Cancer Treatment

Overview

This observational study highlights the significant role of late gadolinium enhancement (LGE) cardiac MRI in detecting myocardial damage in cancer patients undergoing treatment. The presence of LGE was associated with reduced left ventricular ejection fraction (LVEF) and myocardial strain, indicating its potential as a risk factor for cardiotoxicity.

Background

As cancer treatments improve survival rates, the risk of cardiotoxicity becomes a critical concern for oncology patients. These individuals are at a heightened risk of cardiovascular disease, which is a leading cause of noncancer-related mortality. Accurate detection of myocardial damage during cancer therapy is essential for implementing cardioprotective strategies.

Data Highlights

GroupLVEFPeak Strain (PS)
LGE− (n=80)NormalHigher
LGE+ (n=28)ReducedLower

Key Findings

  • The LVEF and peak strain were significantly lower in LGE+ patients compared to LGE− patients (p < 0.05).
  • Moderate to strong correlations were found between circumferential peak diastolic strain rate, peak systolic strain rate, peak strain, and LVEF (r = 0.54 to r = 0.82; p < 0.001).
  • Multivariate analysis revealed independent relationships between N-terminal-pro B-type natriuretic peptide and myocardial strain metrics (p < 0.001).
  • Troponin T levels correlated with circumferential peak diastolic strain rate (p < 0.001).
  • The extent of LGE was significantly associated with circumferential peak strain (p < 0.001).

Clinical Implications

The findings underscore the importance of using LGE cardiac MRI for early detection of myocardial damage in cancer patients. Clinicians should consider integrating this imaging modality into routine assessments to guide cardioprotective measures during cancer therapy.

Conclusion

LGE serves as a critical indicator of left ventricular dysfunction in cancer patients, emphasizing the need for vigilant monitoring of cardiac health in this population.

References

  1. Pediatric Cardiology, 2026 -- Late Gadolinium Enhancement in Surgically Repaired Tetralogy of Fallot May Lead to Overestimation of Right Ventricular Myocardial Fibrosis
  2. European Radiology, 2025 -- Multiparametric Cardiac Magnetic Resonance Without Contrast Enhances Detection of Coronary Microvascular Dysfunction and Structural Impairment Following Percutaneous Coronary Intervention
  3. European Radiology, 2024 -- Evaluation of Techniques for Late Gadolinium Enhancement in Tracking Fibrotic Changes During Myocarditis Follow-Up
  4. European Radiology, 2023 -- Chronic Cardiotoxic Effects in Survivors of Germ Cell Cancer Following Platinum-Based Chemotherapy: Cardiac MRI Reveals Reduced Systolic Function and Tissue Changes
  5. European Heart Journal, 2022 -- 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
  6. PubMed, 2025 -- Beyond ejection fraction: cardiac magnetic resonance imaging in anthracycline cardiotoxicity
  7. PubMed, 2025 -- Diagnostic and Prognostic Value of Cardiac Magnetic Resonance for Cardiotoxicity Caused by Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
  8. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) | European Heart Journal | Oxford Academic
  9. Beyond ejection fraction: cardiac magnetic resonance imaging in anthracycline cardiotoxicity - PubMed
  10. Diagnostic and Prognostic Value of Cardiac Magnetic Resonance for Cardiotoxicity Caused by Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis - PubMed

Original Source(s)

Related Content